Skip to main content
Clinical Trials/NCT03762577
NCT03762577
Completed
Not Applicable

A Randomized Controlled Trial of Ground-based Walking Training for Adult Patients With Pulmonary Hypertension

Istanbul University1 site in 1 country24 target enrollmentDecember 10, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary Hypertension
Sponsor
Istanbul University
Enrollment
24
Locations
1
Primary Endpoint
Endurance exercise capacity
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Pulmonary Hypertension (PH) is a hemodynamic and physiopathological condition that is defined as an increase in pulmonary artery pressure ≥25 mmHg when measured at resting with symptoms such as dyspnea, fatigue, chest pain, and syncope. PH characterized by decreased exercise capacity, quality of life, peripheral muscle strength, balance, and physical inactivity. It is recommended that patients with PH should be included in cardiopulmonary rehabilitation programs in addition to medical treatment. Ground-based walking training is a safe and effective method for COPD patients. In the literature, there are no studies evaluating the effects of ground-based walking training in PH patients.

Detailed Description

The aim of this project is to determine the effect of ground-based walking training on physical activity, exercise capacity, balance, peripheral muscle strength and quality of life in patients with PH.

Registry
clinicaltrials.gov
Start Date
December 10, 2018
End Date
March 4, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ozge Ertan

Physiotherapist

Istanbul University

Eligibility Criteria

Inclusion Criteria

  • 18-80 years
  • Diagnosed with PH
  • Followed by the department of chest diseases at least six months
  • Not participating in the rehabilitation program in last year

Exclusion Criteria

  • Functional group four due to WHO functional classification
  • PH due to left heart diseases, PH due to lung diseases and/or hypoxia
  • Treatment and medication change in the last three months
  • Cooperation problems
  • Patients with successful pulmonary endarterectomy operation
  • Patients with uncontrolled cardiovascular diseases
  • Patients with orthopeadic and/or neurologic disorders that could limit exercise tests
  • Syncope history in recent

Outcomes

Primary Outcomes

Endurance exercise capacity

Time Frame: 8 weeks

endurance shuttle walk test

Study Sites (1)

Loading locations...

Similar Trials